Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Mannose-P-Dolichol Utilization Defect 1 Products

(Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Categories

This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008].

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Featured Mannose-P-Dolichol Utilization Defect 1 Categories

Mannose-P-Dolichol Utilization Defect 1 Antibodies

High quality antibodies with extensive validation data.

Recommended Mannose-P-Dolichol Utilization Defect 1 Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application ELISA, IHC, IF
Validations
  • (2)
Cat. No. ABIN7158987
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (4)
  • (1)
Cat. No. ABIN1881550
Quantity 400 μL
Datasheet Datasheet
Reactivity Human
Application ELISA
Validations
Cat. No. ABIN7158990
Quantity 100 μg
Datasheet Datasheet

Latest Publications for our Mannose-P-Dolichol Utilization Defect 1 products

Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).

Hosgood, Menashe, He, Chanock, Lan: "PTEN identified as important risk factor of chronic obstructive pulmonary disease." in: Respiratory medicine, Vol. 103, Issue 12, pp. 1866-70, (2009) (PubMed).

Shen, Vermeulen, Rajaraman, Menashe, He, Chapman, Yeager, Thomas, Burdett, Hutchinson, Yuenger, Chanock, Lan: "Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China." in: Environmental and molecular mutagenesis, Vol. 50, Issue 4, pp. 285-90, (2009) (PubMed).

Hosgood, Menashe, Shen, Yeager, Yuenger, Rajaraman, He, Chatterjee, Caporaso, Zhu, Chanock, Zheng, Lan: "Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway." in: Carcinogenesis, Vol. 29, Issue 10, pp. 1938-43, (2008) (PubMed).

Synonyms and alternative names related to Mannose-P-Dolichol Utilization Defect 1

mannose-P-dolichol utilization defect 1 (MPDU1), mannose-P-dolichol utilization defect 1 (Mpdu1), mannose-P-dolichol utilization defect 1a (mpdu1a), cystinosin/ERS1p repeat-containing protein (mpdu1), mannose-P-dolichol utilization defect 1 (LOC692905), mannose-P-dolichol utilization defect 1b (mpdu1b), CDGIF, DDBDRAFT_0237930, DDB_0237930, fb18d03, HBEBP2BPA, Lec35, LEC35, mpdu1, MPDU1, My008, PP3958, PQLC5, SL15, Supl15h, wu:fb18d03, zgc:86765, zgc:92112

Protein level used designations for Mannose-P-Dolichol Utilization Defect 1

  • HBeAg-binding protein 2 binding protein A
  • mannose-P-dolichol utilization defect 1 protein
  • suppressor of Lec15 and Lec35 glycosylation mutation homolog
  • suppressor of Lec15 homolog (C.griseus)
  • mannose-P-dolichol utilization defect 1
  • transmembrane protein
  • suppressor of Lec15 glycosylation mutation-like protein
You are here:
Support